Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/100154
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGargett, T.en
dc.contributor.authorBrown, M.en
dc.date.issued2015en
dc.identifier.citationCytotherapy, 2015; 17(4):487-495en
dc.identifier.issn1465-3249en
dc.identifier.issn1477-2566en
dc.identifier.urihttp://hdl.handle.net/2440/100154-
dc.description.abstractBackground aims: Chimeric antigen receptor (CAR) T cells are a novel immunotherapy for cancer. To achieve anti-tumor efficacy, these cells must survive, expand, and persist after infusion into patients, functions that are reportedly best achieved by cells with a stem or central-memory rather than effector-memory phenotype. We have developed third-generation CAR T cells specific for the tumor-associated antigen GD2 for use in a phase I clinical trial. We investigated the optimal cell culture conditions for CAR T-cell production, and here we describe the relative effects of 3 activation and cytokine conditions on CAR T-cell expansion, effector function and phenotype. Methods: Peripheral blood mononuclear cells were activated by anti-CD3 and anti-CD28 or anti-CD3 and Retronectin. Activated cells were transduced with the CAR-encoding retroviral vector and expanded in either interleukin (IL)-2 or IL-7 and IL-15. Immune phenotype and expansion were tracked throughout the culture, and transduction efficiency, and subsequent GD2-specific effector functions were evaluated by flow cytometry and cytotoxic T lymphocytes assay. Results: CD3/Retronectin stimulation with IL-2 resulted in poorer activation, expansion and Th1 cytokine secretion of CAR T cells than CD3/CD28 stimulation with either IL-2 or IL-7 and IL-15. However, CAR T cells cultured in CD3/CD28/IL7/IL-15 and CD3/Retronectin/IL-2 had superior cytotoxic T lymphocyte activity and a more stem-like phenotype. Discussion: The combination of CD3 and CD28 with IL-7 and IL-15 gave the best balance of CAR T-cell expansion and potent GD2-specific effector functions while retaining a stem/memory phenotype, and these growth conditions will therefore be used to manufacture CAR T cells for our phase I clinical trial.en
dc.description.statementofresponsibilityTessa Gargett and Michael P. Brownen
dc.language.isoenen
dc.publisherElsevieren
dc.rightsCrown Copyright © 2015 Published by Elsevier Inc. on behalf of International Society for Cellular Therapy. All rights reserved.en
dc.subjectAnti-CD3 and anti-CD28 stimulation; chimeric antigen receptor T cells; effector function; IL-7; IL-15; IL-2; immune phenotype; Retronectinen
dc.titleDifferent cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2en
dc.typeJournal articleen
dc.identifier.rmid0030023922en
dc.identifier.doi10.1016/j.jcyt.2014.12.002en
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1010386en
dc.identifier.pubid168700-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS14en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidGargett, T. [0000-0003-3713-1373]en
dc.identifier.orcidBrown, M. [0000-0002-5796-1932]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.